Literature DB >> 19892233

The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?

Franz H Messerli1, Gurusher S Panjrath.   

Abstract

The topic of the J-curve relationship between blood pressure and coronary artery disease (CAD) has been the subject of much controversy for the past decades. An inverse relationship between diastolic pressure and adverse cardiac ischemic events (i.e., the lower the diastolic pressure the greater the risk of coronary heart disease and adverse outcomes) has been observed in numerous studies. This effect is even more pronounced in patients with underlying CAD. Indeed, a J-shaped relationship between diastolic pressure and coronary events was documented in treated patients with CAD in most large trials that scrutinized this relationship. In contrast to any other vascular bed, the coronary circulation receives its perfusion mostly during diastole; hence, an excessive decrease in diastolic pressure can significantly hamper perfusion. This adverse effect of too low a diastolic pressure on coronary heart disease leaves the practicing physician with the disturbing possibility that, in patients at risk, lowering blood pressure to levels that prevent stroke or renal disease might actually precipitate myocardial ischemia. However, these concerns should not deter physicians from pursuing a more aggressive control of hypertension, because currently blood pressure is brought to recommended target levels in only approximately one-third of patients. 2009 by the American College of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892233     DOI: 10.1016/j.jacc.2009.05.073

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  82 in total

Review 1.  Epidemiology and prevention of stroke: a worldwide perspective.

Authors:  Elena V Kuklina; Xin Tong; Mary G George; Pooja Bansil
Journal:  Expert Rev Neurother       Date:  2012-02       Impact factor: 4.618

Review 2.  The j-point phenomenon in aggressive therapy of hypertension: new insights.

Authors:  Gurusher S Panjrath; Sameer Chaudhari; Franz H Messerli
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

3.  [Arterial hypertension in patients with coronary artery disease].

Authors:  T Graf; H Schunkert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

4.  On redefining hypertension.

Authors:  Michel Accad; Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2010

Review 5.  Are there benefits of antihypertensive therapy beyond blood pressure lowering?

Authors:  Joseph L Izzo
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

6.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

Review 7.  The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates.

Authors:  Faisal Rahman; John W McEvoy
Journal:  Curr Atheroscler Rep       Date:  2017-08       Impact factor: 5.113

8.  Awareness, attitude, and distribution of high blood pressure among health professionals.

Authors:  Ahmed H Mitwalli; Ahmed Al Harthi; Hussam Mitwalli; Ayman Al Juwayed; Noura Al Turaif; Mohammed A Mitwalli
Journal:  J Saudi Heart Assoc       Date:  2012-11-24

9.  Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.

Authors:  Thomas Weber; Irene Lang; Robert Zweiker; Sabine Horn; Rene R Wenzel; Bruno Watschinger; Jörg Slany; Bernd Eber; Franz Xaver Roithinger; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2016-06-09       Impact factor: 1.704

10.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.

Authors:  Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.